Presbia PLC Appoints Dr. Gerd Auffarth to the Board of Directors
DUBLIN--(BUSINESS WIRE)--The Board of Directors of Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near vision restoration, announced today that it has appointed Dr. Gerd Auffarth, M.D., Ph.D. to the board. The board also announced the appointment of Dr. Mark Blumenkranz to the Presbia Medical Advisory Board. Dr. Auffarth is Director of the International Vision Correction Research Centre (IVCRC) and The David J. Apple International Laboratory for Ophthalmic Pathology. Dr.
